|
1
|
Wenzel U, Kuntz S, Brendel MD and Daniel
H: Dietary flavone is a potent apoptosis inducer in human colon
carcinoma cells. Cancer Res. 60:3823–3831. 2000.PubMed/NCBI
|
|
2
|
Nualsanit T, Rojanapanthu P, Gritsanapan
W, Lee SH, Lawson D and Baek SJ: Damnacanthal, a noni component,
exhibits antitumorigenic activity in human colorectal cancer cells.
J Nutr Biochem. 23:915–923. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sukamporn P, Rojanapanthu P, Silva G,
Zhang X, Gritsanapan W and Baek SJ: Damnacanthal and its
nanoformulation exhibit anti-cancer activity via cyclin D1
down-regulation. Life Sci. 152:60–66. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin FL, Hsu JL, Chou CH, Wu WJ, Chang CI
and Liu HJ: Activation of p38 MAPK by damnacanthal mediates
apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α
and p53 pathways. Eur J Pharmacol. 650:120–129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Faltynek CR, Schroeder J, Mauvais P,
Miller D, Wang S, Murphy D, Lehr R, Kelley M, Maycock A, Michne W,
et al: Damnacanthal is a highly potent, selective inhibitor of
p56lck tyrosine kinase activity. Biochemistry. 34:12404–12410.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Garcia-Vilas JA, Quesada AR and Medina MA:
Damnacanthal, a noni anthraquinone, inhibits c-Met and is a potent
antitumor compound against Hep G2 human hepatocellular carcinoma
cells. Sci Rep. 5:80212015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ohashi K, Sampei K, Nakagawa M, Uchiumi N,
Amanuma T, Aiba S, Oikawa M and Mizuno K: Damnacanthal, an
effective inhibitor of LIM-kinase, inhibits cell migration and
invasion. Mol Biol Cell. 25:828–840. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sukamporn P, Baek SJ, Gritsanapan W,
Chirachanchai S, Nualsanit T and Rojanapanthu P: Self-assembled
nanomicelles of damnacanthal-loaded amphiphilic modified chitosan:
Preparation, characterization and cytotoxicity study. Mater Sci Eng
C Mater Biol Appl. 77:1068–1077. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kanai M, Hanashiro K, Kim SH, Hanai S,
Boulares AH, Miwa M and Fukasawa K: Inhibition of Crm1-p53
interaction and nuclear export of p53 by poly(ADP-ribosyl)ation.
Nat Cell Biol. 9:1175–1183. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
El-Tanani M, Dakir el-H, Raynor B and
Morgan R: Mechanisms of nuclear export in cancer and resistance to
chemotherapy. Cancers (Basel). 8:pii: E352016. View Article : Google Scholar
|
|
11
|
Gravina GL, Senapedis W, McCauley D,
Baloglu E, Shacham S and Festuccia C: Nucleo-cytoplasmic transport
as a therapeutic target of cancer. J Hematol Oncol. 7:852014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Min KW, Liggett JL, Silva G, Wu WW, Wang
R, Shen RF, Eling TE and Baek SJ: NAG-1/GDF15 accumulates in the
nucleus and modulates transcriptional regulation of the Smad
pathway. Oncogene. 35:377–388. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun Q, Chen X, Zhou Q, Burstein E, Yang S
and Jia D: Inhibiting cancer cell hallmark features through nuclear
export inhibition. Signal Transduct Target Ther. 1:160102016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nualsanit T, Rojanapanthu P, Gritsanapan
W, Kwankitpraniti T, Min KW and Baek SJ: Damnacanthal-induced
anti-inflammation is associated with inhibition of NF-κB activity.
Inflamm Allergy Drug Targets. 10:455–463. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baek SJ, Okazaki R, Lee SH, Martinez J,
Kim JS, Yamaguchi K, Mishina Y, Martin DW, Shoieb A, McEntee MF and
Eling TE: Nonsteroidal anti-inflammatory drug-activated gene-1 over
expression in transgenic mice suppresses intestinal neoplasia.
Gastroenterology. 131:1553–1560. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aziz MY, Omar AR, Subramani T, Yeap SK, Ho
WY, Ismail NH, Ahmad S and Alitheen NB: Damnacanthal is a potent
inducer of apoptosis with anti-cancer activity by stimulating p53
and p21 genes in MCF-7 breast cancer cells. Oncol Lett.
7:1479–1484. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cancer Registry Unit NCIT: Cancer in
Thailand. VIII. New Thammada Press (Thailand) Co., Ltd.; 2015
|
|
18
|
Potter JD, Slattery ML, Bostick RM and
Gapstur SM: Colon cancer: A review of the epidemiology. Epidemiol
Rev. 15:499–545. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chan-Blanco Y, Vaillant F, Pérez A, Reynes
R, Brillouet JM and Brat P: The noni fruit (Morinda citrifolia L.):
A review of agricultural research, nutritional and therapeutic
properties. J Food Comp Analy. 19:645–654. 2006. View Article : Google Scholar
|
|
20
|
Ishizawa J, Kojima K, Hail N Jr, Tabe Y
and Andreeff M: Expression, function, and targeting of the nuclear
exporter chromosome region maintenance 1 (CRM1) protein. Pharmacol
Ther. 153:25–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yao Y, Dong Y, Lin F, Zhao H, Shen Z, Chen
P, Sun YJ, Tang LN and Zheng SE: The expression of CRM1 is
associated with prognosis in human osteosarcoma. Oncol Rep.
21:229–235. 2009.PubMed/NCBI
|
|
22
|
Noske A, Weichert W, Niesporek S, Röske A,
Buckendahl AC, Koch I, Sehouli J, Dietel M and Denkert C:
Expression of the nuclear export protein chromosomal region
maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian
cancer. Cancer. 112:1733–1743. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang WY, Yue L, Qiu WS, Wang LW, Zhou XH
and Sun YJ: Prognostic value of CRM1 in pancreas cancer. Clin
Invest Med. 32:E3152009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shen A, Wang Y, Zhao Y, Zou L, Sun L and
Cheng C: Expression of CRM1 in human gliomas and its significance
in p27 expression and clinical prognosis. Neurosurgery. 65:153–160.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
van der Watt PJ, Maske CP, Hendricks DT,
Parker MI, Denny L, Govender D, Birrer MJ and Leaner VD: The
Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed
in cervical cancer and are critical for cancer cell survival and
proliferation. Int J Cancer. 124:1829–1840. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Inoue H, Kauffman M, Shacham S, Landesman
Y, Yang J, Evans CP and Weiss RH: CRM1 blockade by selective
inhibitors of nuclear export attenuates kidney cancer growth. J
Urol. 189:2317–2326. 2013. View Article : Google Scholar : PubMed/NCBI
|
